Laura Flannery, MD
Internal Medicine Physician in Columbus, Ohio.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 174,792 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Laura Flannery, MD filed 540 Medicare Part D claims in 2024 as an Internal Medicine Physician in Columbus, Ohio, prescribing 83% generic.
- 540
- Part D claims, 2024
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Laura Flannery, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1891058582), first enumerated 06/19/2012.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 540 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$8.4K in reported industry payments (161 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Ohio statewide board action statistics are published annually — these figures describe aggregate state activity, not Laura Flannery, MD's individual license status. Verify directly with the state medical board.
Source: OMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1891058582 · Internal Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · RX-LIGHT · BOOK-MID · PHOTO-ENUM
- NPI-10 1891058582
- ENUM-MID 2012
- TAX-MEGA 175K Internal Medicine
- RX-LIGHT 540
- BOOK-MID 5,995 in Ohio
- PHOTO-ENUM Pradeep Kadimcherla,… · 2012
Laura Flannery, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
540 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Laura Flannery, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Laura Flannery, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Ohio
How Internal Medicine Physician compares to other specialties among Ohio providers
Internal Medicine Physician ranks #15 among Ohio's specialties (1.8% of in-state providers)
Each bar is a specialty's share of the Ohio provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1891058582 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/19/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Laura Flannery, MD's current license status, disciplinary history, and board certifications with the State Medical Board of Ohio in Ohio before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1891058582 is the unique 10-digit identifier CMS uses to link Flannery across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Laura Flannery, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Laura Flannery, MD. Source: openpaymentsdata.cms.gov.
Total received
$8.4K
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Ohio OMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Laura Flannery, MD. To verify Laura Flannery, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 540 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,018.267
- Total Day Supply
- 30,327
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $73K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 2.01
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 17, 65-74: 49, 75-84: 42, 85+: 17
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Laura Flannery, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clopidogrel
Clopidogrel
108 claims
- Metoprolol Succinate
Metoprolol Succinate
63 claims
- Atorvastatin Calcium
Atorvastatin Calcium
51 claims
- Furosemide 43
Furosemide
43 claims
- Eliquis 42
Eliquis
42 claims
- Ezetimibe 34
Ezetimibe
34 claims
- Amlodipine Besylate 24
Amlodipine Besylate
24 claims
- Losartan Potassium 23
Losartan Potassium
23 claims
| Drug | Claims |
|---|---|
| Clopidogrel Clopidogrel Bisulfate | 108 |
| Metoprolol Succinate | 63 |
| Atorvastatin Calcium | 51 |
| Furosemide | 43 |
| Eliquis Apixaban | 42 |
| Ezetimibe | 34 |
| Amlodipine Besylate | 24 |
| Losartan Potassium | 23 |
| Carvedilol | 16 |
| Entresto Sacubitril/Valsartan | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Laura Flannery, MD fits within the Internal Medicine Physician landscape nationally.
Laura Flannery, MD's 540 claims are below the specialty average of 2,785.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Flannery, both outside Ohio so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Flannery.
One of 5,995 Internal Medicine Physician providers enrolled in Ohio, 5 are shown here.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Laura Flannery, MD's specialty? ▼
How much does Laura Flannery, MD prescribe under Medicare Part D? ▼
Where is Laura Flannery, MD located? ▼
What is Laura Flannery, MD's NPI number? ▼
Does Laura Flannery, MD prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Laura Flannery, MD prescribe most often? ▼
Does Laura Flannery, MD accept Medicare? ▼
How can I verify Laura Flannery, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.